Line 28: | Line 28: | ||
'''We have designed a tool based on CRISPR/Cas9 property to target a specific DNA sequence. We imagined a system using dCas9 that dimerizes under an induction signal to bring two DNA sequence closer. ''' | '''We have designed a tool based on CRISPR/Cas9 property to target a specific DNA sequence. We imagined a system using dCas9 that dimerizes under an induction signal to bring two DNA sequence closer. ''' | ||
− | A dCas9 is a protein which | + | |
+ | A dCas9 is a protein which recognizes precisely a DNA sequence without nuclease activity. We chose this system for it high adaptability, as it targets DNA through a sgRNA which could be easily designed. But as we need to target two different sequences we also need to work with dCas9s which will not interfere with each other, we chose two orthologous dCas9s which expressed different organisms as ''T. denticola'' (TD) and ''S. pyogenes'' (SP). As they come from different organisms, they recognize different sgRNAs thanks to their PAM sequence. We ordered from Addgene the plasmid coding for each one of these dCas9s and their sgRNAs. | ||
[[Image:Image1design.jpg|frameless|center|upright=2.5|alt=dCas9 mecanism]] | [[Image:Image1design.jpg|frameless|center|upright=2.5|alt=dCas9 mecanism]] | ||
− | To dimerize this two dCas9s we | + | To dimerize this two dCas9s, we chose an inducible system using FRB and FKBP12 proteins. Originally found in mammals, these two proteins form an heterodimer when rapamycin is added in the middle, it is particularly used in protein interaction studies (Cui et al., 2014). However, rapamycin is toxic for bacteria, but studies showed that a mutated FRB (FRB*) still allows dimerization with an analog of rapamycin non toxic called rapalog. The mutations implied are: T2098L, K2095P, W2101F.(Bayle et al., 2006; Liberles, Diver, Austin, & Schreiber, 1997). |
− | A biobrick coding FRB with mutation T2098L was already in | + | A biobrick coding FRB with mutation T2098L was already in registry (iGEM Part_ J18926) but was not available. Moreover, it contains only one mutation on the 3 described in the literature. So we decided to work with the fully mutant FRB. Rapalog and plasmid with mutant FRB and FKBP12 were offered to us by Takara Clontech. But like it was mentioned previously, this system is used in mammal cells, so we decide to optimize the sequences for an expression in ''E. coli'' with the Jcat plateforme. So we finally order gBlocks coding for the FRB* and FKBP12 optimized sequences and a linker in prevision for the fusion with their respective dCas9s. |
Using these two systems (dCas9 recognition and FRB/FKBP12 dimerization) we design our new tool based on the two following BioBricks: | Using these two systems (dCas9 recognition and FRB/FKBP12 dimerization) we design our new tool based on the two following BioBricks: | ||
Line 40: | Line 41: | ||
[[Image:Image2design.jpg|frameless|center|upright=2.5|alt=dCas9 mecanism]] | [[Image:Image2design.jpg|frameless|center|upright=2.5|alt=dCas9 mecanism]] | ||
− | These two biobricks will be assembled in pSB1C3 plasmid giving us our BDC tool which | + | These two biobricks will be assembled in pSB1C3 plasmid giving us our BDC tool which would work as presented bellow: |
[[Image:Image3design.jpg|frameless|center|upright=2|alt=dCas9 mecanism]] | [[Image:Image3design.jpg|frameless|center|upright=2|alt=dCas9 mecanism]] | ||
Line 46: | Line 47: | ||
=Visualization tool construction= | =Visualization tool construction= | ||
− | ''' | + | '''As every systems need an efficient control, we set up a new part of the project in order to asses our Bring DNA Closer tool: the visualization tool.''' |
− | To build this new tool, two other orthologous | + | To build this new tool, two other orthologous dCas9s were used: ''N. meningitidis'' and ''S. thermophilus''. These dCas9 were fused to fluorescent proteins. We also decided to use dCas9 system for this tool in order to have detection of a accurate and unique sequence in the genome. It will be fulfilling with a new and unreleased in the iGEM competition tripartite slip-GFP. |
− | The | + | The tripartite split-GFP is composed of two twenty amino-acids long GFP tags (GFP 10 and GFP 11) and a third complementary subsection (GFP 1-9). The tags were fused to the two dCas9 previously quoted. A functional GFP would be formed when the tools would be close enough to allow the three slip-GFP parts reunion and the fluorescence emission. This fluorescence system avoids poor folding and/or self-assembly background fluorescence. With this system, only two sgRNAs associated with their dCas9s fused to their specific GFP tags were necessary instead of nearly 30 with mundane GFP due to background fluorescence. |
− | + | We designed three biobricks to achieve this part of the project: | |
* '''BioBrick n°3 :''' ''N.meningitidis'' fused to GFP-10 expressed by a constitutive promoter, a RBS and a double terminator | * '''BioBrick n°3 :''' ''N.meningitidis'' fused to GFP-10 expressed by a constitutive promoter, a RBS and a double terminator | ||
Line 62: | Line 63: | ||
[[File:T--Paris_Saclay--visualization_biobricks.jpeg|frameless|center|upright=2.5|]] | [[File:T--Paris_Saclay--visualization_biobricks.jpeg|frameless|center|upright=2.5|]] | ||
− | Then, | + | Then, we considered to establish a composite biobrick composed of the three biobricks in the same pSB1C3 plasmid. This plasmid would have been build using the iGEM restriction site technique. |
[[File:T--Paris_Saclay--composite_visualization_biobrick.jpeg|upright=2.5|frameless|center|]] | [[File:T--Paris_Saclay--composite_visualization_biobrick.jpeg|upright=2.5|frameless|center|]] | ||
[[File:T--Paris_Saclay--visualization2.jpeg|frameless|center|upright=2.5|]] | [[File:T--Paris_Saclay--visualization2.jpeg|frameless|center|upright=2.5|]] | ||
− | + | We chose to express sgRNAs on another plasmid pZA11 which is compatible with pSB1C3, as it is Amp resistant. | |
− | + | ||
− | + | ||
[[File:T--Paris Saclay--visualization sgRNA.jpeg|upright=2.5|frameless|center|]] | [[File:T--Paris Saclay--visualization sgRNA.jpeg|upright=2.5|frameless|center|]] | ||
Line 88: | Line 87: | ||
Nguyen, Hau B et al. 2013. “A New Protein-Protein Interaction Sensor Based on Tripartite Split-GFP Association.” Scientific Reports 10: 1–9. | Nguyen, Hau B et al. 2013. “A New Protein-Protein Interaction Sensor Based on Tripartite Split-GFP Association.” Scientific Reports 10: 1–9. | ||
− | |||
− | |||
{{Team:Paris_Saclay/project_footer}} | {{Team:Paris_Saclay/project_footer}} |
Revision as of 13:42, 9 October 2016